The $67m venture financing of Neurolenses was the medical devices industry’s top cross border venture financing deal as total deals worth $410.5m were announced globally in September 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 7.2% over the previous month of $442.37m and a drop of 54.4% when compared with the last 12-month average, which stood at $899.42m.
Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $198.22m. At the country level, the US topped the list in terms of deal value at $194.3m.
In terms of volumes, Europe emerged as the top region for medical devices industry cross border venture financing deals globally, followed by North America and then Asia-Pacific.
The top country in terms of cross border venture financing deals activity in September 2022 was the US with eight deals, followed by the China with five and Switzerland with four.
In 2022, as of September, medical devices cross border venture financing deals worth $7.33bn were announced globally, marking an increase of 33.04% year on year.
medical devices industry cross border venture financing deals in September 2022: Top deals
The top five medical devices industry cross border venture financing deals accounted for 54.3% of the overall value during September 2022.
The combined value of the top five medical devices cross border venture financing deals stood at $222.98m, against the overall value of $410.5m recorded for the month.
The top five medical devices industry cross border venture financing deals of September 2022 tracked by GlobalData were:
1) Bluestem Capital Company, Falcon Vision Global, Marshall Wace and MVM Partners’s $67m venture financing deal with Neurolenses
2) The $50m venture financing of Ceribell by Ally Bridge Group
3) 415 Capital Management, Andera Partners, BioMedPartners, Credit Mutuel Innovation, Go Capital , Karista and Wellington Partners Venture Capital’s $46.94m venture financing deal with TRiCares
4) The $32m venture financing of CXL Ophthalmics by AXA IM Alts1
5) AXA Venture Partners, Bpifrance Financement, Karista, LBO France and Wille Finance’s $27.03m venture financing deal with Incepto Medical